[Therapy of chronic postprandia dyspepsia. Crossed double-blind study with Domperidon (Motilium)].
In a double-blind cross-over study over eight weeks two groups of 24 patients each with symptoms of chronic postprandial dyspepsia received during the first four-week period either 10 mg domperidon t.i.d. or placebo. After four weeks the medication was exchanged. Despite some improvement of symptoms under placebo, statistical analysis revealed a significantly higher improvement rate after domperidon.
D000293:Adolescent; D000328:Adult; D004311:Double-Blind Method; D004341:Drug Evaluation; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D005768:Gastrointestinal Hormones / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009037:Motilin / Q000627:therapeutic use*
D005768:Gastrointestinal Hormones; D009037:Motilin
Zur Therapie der chronischen postprandialen Dyspepsie. Gekreuzter Doppelblind-Versuch mit Domperidon (Motilium).